Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
Authors
Keywords
-
Journal
BIOLOGICAL TRACE ELEMENT RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-11-28
DOI
10.1007/s12011-020-02512-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
- (2020) Heshui Shi et al. LANCET INFECTIOUS DISEASES
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
- (2020) Matthieu Million et al. Travel Medicine and Infectious Disease
- Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
- (2020) Shiv Kumar Sarin et al. Hepatology International
- Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
- (2020) Sherief Abd-Elsalam et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Zinc and COVID-19: Basis of Current Clinical Trials
- (2020) Amit Pal et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
- (2020) Thibault Fiolet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
- (2020) Thomas Marjot et al. JOURNAL OF HEPATOLOGY
- Molecular and functional resemblance of dexamethasone and quercetin: A paradigm worth exploring in dexamethasone‐nonresponsive COVID ‐19 patients
- (2020) Anil Pawar et al. PHYTOTHERAPY RESEARCH
- SARS-CoV-2: The Path of Prevention and Control
- (2020) Amal A. Mohamed et al. Infectious Disorders - Drug Targets
- Chloroquine as Chemoprophylaxis for COVID-19: Will This Work
- (2020) Sherief Abd-Elsalam et al. Infectious Disorders - Drug Targets
- T cell-mediated immune response to respiratory coronaviruses
- (2014) Rudragouda Channappanavar et al. IMMUNOLOGIC RESEARCH
- Zinc Ionophore Activity of Quercetin and Epigallocatechin-gallate: From Hepa 1-6 Cells to a Liposome Model
- (2014) Husam Dabbagh-Bazarbachi et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Chloroquine Is a Zinc Ionophore
- (2014) Jing Xue et al. PLoS One
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
- (2010) Aartjan J. W. te Velthuis et al. PLoS Pathogens
- Role of Zn2+ Ions in Host-Virus Interactions
- (2008) M. Lazarczyk et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started